Pharmaceutical Companies, Intellectual Property

935 Words4 Pages
Case Study #1
“Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic”
Questions for Review: 1. Do pharmaceutical companies have a responsibility to distribute drugs for free or at low cost in developing countries? What are the main arguments for and against such an approach? What are the advantages and disadvantages of giving drugs for free versus offering them at low no-profit prices?
-I don’t necessarily think that they have the “responsibility” to do so but I think that they should want to as there are millions dying and suffering tremendously from this epidemic. Pharmaceutical companies make billions and billions of dollars a year, I feel that they should want to help people who can’t help themselves.
…show more content…
-I agree that it is an appropriate change in policy. People tend to get greedy when large amounts of profit come flowing in blinding them of people’s real needs for help. The benefit of protecting the pharmaceutical patents is that it helps the poor get drugs at a lower cost actually giving them a chance, everyone deserves a chance. We are economically the most advanced compared to any other country we should want to help those who don’t have the means to help themselves. As many could potentially benefit from this policy it does have its problems. This policy would bring along some negative impact. For example, Pharmaceutical companies could face long term threats along with other risks.

5. Given the initiatives announced by global development and aid organizations and among pharmaceutical companies themselves, was it necessary to relax IPR rules in order to ensure that adequate supplies of AIDS medications would be available for distribution in the developing world?
-I think that it is necessary to relax some of the IPR rules. IPRS protect creativity and innovation for the investors making it harder for people to use inventor’s ideas without permission, I think that we should protect intellectual property rights of the pharmaceutical companies. To ensure that adequate announced supplies of AIDS medications would be available for distribution in the developing world, yes I believe IPR rules should be relaxed.

Open Document